Scarica l'app Stockscreener
7.54
3.01%
0.22
Dopo l'orario di chiusura:
7.54
Fulcrum Therapeutics Inc Borsa (FULC) Ultime notizie
Acadian Asset Management LLC Increases Stock Position in Fulcrum Therapeutics, Inc. $FULC - Defense World
Jacobs Levy Equity Management Inc. Purchases New Shares in Fulcrum Therapeutics, Inc. $FULC - MarketBeat
Here's Why We're Not Too Worried About Fulcrum Therapeutics' (NASDAQ:FULC) Cash Burn Situation - Yahoo Finance
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
Aug PostEarnings: Will Fulcrum Therapeutics Inc outperform tech stocksTrade Analysis Summary & Community Verified Trade Signals - خودرو بانک
Risk Check: Can Fulcrum Therapeutics Inc disrupt its industry2025 Breakouts & Breakdowns & Daily Profit Focused Stock Screening - خودرو بانک
Fulcrum reduces its workforce - MSN
Published on: 2025-09-16 21:20:39 - خودرو بانک
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Short Interest Update - MarketBeat
Trading Action: Will Immunocore Holdings plc Depositary Receipt outperform tech stocksTrade Analysis Summary & Free Expert Verified Stock Movement Alerts - خودرو بانک
Guidance Update: Can Fulcrum Therapeutics Inc keep up with sector leadersJuly 2025 Review & Safe Swing Trade Setup Alerts - خودرو بانک
Technical analysis overview for Fulcrum Therapeutics Inc. stock2025 Key Highlights & Consistent Return Investment Signals - newser.com
Published on: 2025-09-16 05:16:04 - خودرو بانک
Market Overview: Is IF Bancorp Inc in a long term uptrendStock Surge & High Yield Equity Trading Tips - خودرو بانک
Aug Update: Is Fulcrum Therapeutics Inc in a bullish channelWeekly Investment Recap & Free Technical Confirmation Trade Alerts - خودرو بانک
Market Catalysts: Is Fulcrum Therapeutics Inc benefiting from innovation trendsJuly 2025 Patterns & Expert Approved Momentum Ideas - خودرو بانک
Applying chart zones and confluence areas to Fulcrum Therapeutics Inc.Portfolio Update Summary & Stepwise Entry and Exit Trade Signals - newser.com
Fulcrum Therapeutics, Inc. $FULC Shares Bought by Exome Asset Management LLC - MarketBeat
Published on: 2025-09-15 03:06:05 - newser.com
Using flow based indicators on Fulcrum Therapeutics Inc.2025 Fundamental Recap & Consistent Profit Alerts - newser.com
Volume spikes in Fulcrum Therapeutics Inc. stock – what they meanPortfolio Return Report & Technical Entry and Exit Tips - newser.com
147,654 Shares in Fulcrum Therapeutics, Inc. $FULC Acquired by Jacobs Levy Equity Management Inc. - Defense World
Institutional scanner results for Fulcrum Therapeutics Inc.Market Growth Summary & Stepwise Trade Execution Plans - Newser
Is Fulcrum Therapeutics Inc. reversing from oversold territoryJuly 2025 Sector Moves & Weekly Chart Analysis and Trade Guides - Newser
Invesco Ltd. Acquires 55,791 Shares of Fulcrum Therapeutics, Inc. $FULC - MarketBeat
Short interest data insights for Fulcrum Therapeutics Inc.Insider Buying & Technical Confirmation Trade Alerts - Newser
Fulcrum Therapeutics Inc. stock retracement – recovery analysisJuly 2025 Analyst Calls & Safe Capital Allocation Plans - Newser
Top chart patterns to watch in Fulcrum Therapeutics Inc.Market Movers & Low Drawdown Momentum Trade Ideas - Newser
Will a bounce in Fulcrum Therapeutics Inc. offer an exitTrade Exit Summary & Risk Controlled Stock Alerts - Newser
What’s next for Fulcrum Therapeutics Inc. stock priceJuly 2025 PostEarnings & Community Consensus Trade Alerts - Newser
Real time breakdown of Fulcrum Therapeutics Inc. stock performanceTrade Signal Summary & Entry Point Strategy Guides - Newser
Fulcrum Therapeutics reports inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener
How to use Fibonacci retracement on Fulcrum Therapeutics Inc.July 2025 PreEarnings & Weekly Breakout Opportunity Watchlist - Newser
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Custom watchlist performance reports with Fulcrum Therapeutics Inc.2025 Pullback Review & Long Hold Capital Preservation Tips - Newser
Using Ichimoku Cloud for Fulcrum Therapeutics Inc. technicalsWeekly Trading Summary & Free Expert Approved Momentum Trade Ideas - Newser
Analyzing recovery setups for Fulcrum Therapeutics Inc. investorsStop Loss & Daily Stock Trend Reports - Newser
Will Fulcrum Therapeutics Inc. benefit from macro trendsWeekly Gains Report & Safe Capital Growth Trade Ideas - Newser
What institutional flow reveals about Fulcrum Therapeutics Inc.July 2025 Pullbacks & Daily Stock Trend Watchlist - Newser
Is this a good reentry point in Fulcrum Therapeutics Inc.2025 Trading Recap & Weekly Watchlist for Hot Stocks - Newser
Is Fulcrum Therapeutics Inc. stock entering bullish territoryJuly 2025 Short Interest & Proven Capital Preservation Methods - Newser
Fulcrum Therapeutics Inc. stock prediction for this weekIndex Update & Safe Entry Zone Tips - Newser
Market reaction to Fulcrum Therapeutics Inc.’s recent newsJuly 2025 Technicals & Technical Pattern Alert System - Newser
Combining machine learning predictions for Fulcrum Therapeutics Inc.Market Volume Report & Daily Entry Point Trade Alerts - Newser
Strategies to average down on Fulcrum Therapeutics Inc.July 2025 Technicals & Verified Entry Point Signals - Newser
How sentiment analysis helps forecast Fulcrum Therapeutics Inc.Gold Moves & Fast Entry Momentum Trade Alerts - Newser
Fulcrum Therapeutics Inc. stock daily chart insightsJuly 2025 Setups & Weekly High Return Forecasts - Newser
Using Bollinger Bands to evaluate Fulcrum Therapeutics Inc.Quarterly Earnings Report & Consistent Profit Trading Strategies - Newser
Has Fulcrum Therapeutics Inc. formed a bullish divergence2025 Biggest Moves & Long-Term Investment Growth Plans - Newser
0.25%
0.14%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):